ArticleOncology reports2013

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth.

Douglas C Marchion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.